ArticleOncotarget2016

Dasatinib-loaded albumin nanoparticles possess diminished endothelial cell barrier disruption and retain potent anti-leukemia cell activity.

Chunling Dong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.